Great West Life Assurance CO Vertex Pharmaceuticals Inc Transaction History
Great West Life Assurance CO
- $57.4 Billion
- Q3 2024
A detailed history of Great West Life Assurance CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 318,281 shares of VRTX stock, worth $143 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
318,281
Previous 320,284
0.63%
Holding current value
$143 Million
Previous $150 Million
1.32%
% of portfolio
0.26%
Previous 0.28%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,723Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.1 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.4 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.6 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.32 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.05 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $116B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...